Operating with a strong sense of business integrity and corporate responsibility is critical to maintain trust and credibility. BioClinica's management team is comprised of clinical trial experts with years of clinical trial, bioimaging, data management, business management, technology and pharmaceutical industry experience. Together, our clinical trial experts are dedicated to deliver better results for all of our clients' clinical trials, globally.
- John Hubbard, Ph.D., FCP, President, Chief Executive Officer and Member of the Board of Directors
- Ted Kaminer, CPA, Executive V.P., Finance & Administration, Chief Financial Officer
- David S. Herron, Executive V.P., President, Medical Imaging & Cardiac Safety
- Mukhtar Ahmed, President, eClinical Solutions
- Garry D. Johnson, Executive V.P., Chief Technology Officer (CTO)
- Douglas Cory, Vice President, eClinical Solutions Development
- Jim Dorsey, Vice President, Global Marketing
- Paul Hopper, Vice President, Enterprise Information Technology
- Maria Kraus, Vice President, Corporate Controller
- Colleen LoConte, Vice President, Program Management
- Carmella Miller, Vice President Corporate Human Resources
- Emmanuel Olart, Vice President, Medical Imaging Solutions Development
Medical Imaging and Cardiovascular Solutions Management
- John Blank, Vice President and Head of Cardiovascular Services
- Robbie Chana, MBA, Vice President, Global Business Development
- Mark Endres, Head of Global Business Development
- Thomas Fuerst, Chief Science Officer, Head of Musculoskeletal
- Todd Kisner, Vice President, Quality & Regulatory Affairs
- Boaz Mendzelevski, MD, Vice President, Cardiology
- Colin G. Miller, Ph.D. F.I.C.R, CSci, Vice President, Strategic Development
- J. Michael O'Neal, MD, Chief Medical Officer, Head of Oncology
- Joyce Suhy, Ph.D., Head of Neuroscience
eClinical Solutions Management
- Jonathan Andrus, Vice President, Strategic Accounts & eClinical Solutions
- Stephen Boccardo, Senior Vice President, Global Business Development
- Dave Bowser, Senior Vice President, Business Operations and Consulting
- Claudine Paccio, Vice President, eClinical Operations
John Hubbard, Ph.D., FCP, President, Chief Executive Officer and Member of the Board of Directors
Dr. John Hubbard is the President and CEO of BioClinica. He is a leader in the Clinical Services and Biopharmaceutical R&D industries, with over three decades of experience including executive level positions at Pfizer, ICON, Parexel and Hoechst Marion Roussel Pharmaceuticals.
Prior to joining BioClinica, he was Senior Vice President and Worldwide Head of Development Operations for Pfizer, where he directed and oversaw clinical trial operations and management of more than 450 clinical projects. Dr. Hubbard was also a founding member of the Board of Directors of TransCelerate Biopharma, Inc. Before joining Pfizer, Dr. Hubbard was Group President, Clinical Research Services at ICON Clinical Research, a top five global clinical research organization. He is also a Board Member of Agile Therapeutics, a Board Member of the Association of Clinical Research Organizations (ACRO), and an Advisory Board Member and Fundraising Vice-chair for the Children's Brain Tumor Foundation.
Dr. Hubbard received a Bachelor of Science degree in Biopsychology from the University of Santa Clara and a Doctorate from the University of Tennessee, with a research focus on the genetic basis of hypertension and autonomic dysfunction. He was an NIH Postdoctoral Fellow in Cardiovascular and Clinical Pharmacology at the University of Texas Health Sciences Center. Dr. Hubbard is an active member of the Society of Clinical Pharmacology and Therapeutics, a Board Certified Diplomate in Applied Pharmacology and was elected as a Fellow of the American College of Clinical Pharmacology (ACCP). He has authored/co-authored three book chapters and 76 published articles and abstracts in the areas of biopsychology, cardiovascular and autonomic pharmacology, clinical pharmacology, and global drug development.
Mr. Kaminer is responsible for BioClinica's financial, legal, human resources and regulatory functions. Mr. Kaminer joined BioClinica in February 2003 as Senior Vice President and Chief Financial Officer. Prior to joining BioClinica, Mr. Kaminer served as Chief Financial Officer and Vice President of ION Networks Inc. Before his association with ION Networks, Mr. Kaminer served as Senior Vice President of Finance and Chief Financial Officer of CMPExpress and he spent twelve years with various investment banking firms providing corporate finance services such as public and private financings, mergers and acquisitions and other financial advisory services primarily to middle-market companies. Mr. Kaminer is a certified public accountant and was previously associated with Price Waterhouse (the predecessor of PricewaterhouseCoopers). Mr. Kaminer received his Bachelor of Science degree from Cornell University and his MBA from The Wharton School, University of Pennsylvania.
Mr. Herron is responsible for the global strategic planning and operations of BioClinica's medical imaging management solutions which include software and services for the electronic transfer, management, and independent review of medical images for clinical trials. Prior to joining BioClinica, Mr. Herron served as an Executive in Residence with DW Healthcare Partners, a private equity firm focused on healthcare opportunities. Before DW Healthcare, he spent four years at CCBR-SYNARC where Mr. Herron began as VP of Sales and progressed to serve as Chief Operating Officer. Throughout his career, Mr. Herron has held positions of increasing responsibility in a variety of healthcare industries including clinical research organizations, centralized imaging laboratories, healthcare information technologies, managed care, managed pharmacy, and international consulting firms focused on information technologies, healthcare and time-loss management. Mr. Herron's healthcare experience follows a seventeen-year career in the United States military where he served in the US Marine Corps and the Adjutant General Corps USA. He was awarded three combat service medals during Operations Desert Shield and Desert Storm. Mr. Herron received his Bachelor's Degree with honors from Lipscomb University, in partnership with Vanderbilt University.
Mr. Ahmed is responsible for the global strategy and operations of BioClinica's eClinical Solutions Division which provides technology and services to the clinical trial research industry. Mr. Ahmed joined BioClinica in 2015, having previously served as Global Vice President at Oracle Corporation where he was responsible for growing Global Consulting Services and leading the Life Sciences business toward transformative cloud platforms, big data solutions and digital medicine. Mr. Ahmed has held senior executive positions with multinational Contract Research Organizations and clinical informatics companies including Kendle, Parexel and Medidata. He has also held board-level, non-executive posts with National Health Service primary care and strategic health trusts in the United Kingdom and is an industry advisor to a number of start-ups and mid-range private equity companies. Mr. Ahmed is routinely an industry speaker on topics including scientific innovation, strategic outsourcing, business change management, and clinical technologies. He earned degrees including a B.S. in Applied Systems and an M.S. in Neurological Imaging from Brunel University, as well as an MBA and post graduate diploma in Computer Science from Buckinghamshire University College.
Mr. Johnson leads the company's global technology strategy, including developing and implementing BioClinica's technology plan, overseeing technology investments and ensuring that operational efficiencies are maximized. Mr. Johnson previously served as Senior Vice President and Global Chief Technology officer for Dendrite International, Inc. (now Cegedim Dendrite). Prior to Dendrite, Mr. Johnson held leadership positions at Boron Lepore, Inc. (now Cardinal Health) and AlliedSignal, Inc. (now Honeywell). Mr. Johnson earned a bachelor's degree in management from Fairfield University in Fairfield, CT.
Mr. Cory is responsible for new eClinical product development for BioClinica. Mr. Cory was a founder of Phoenix Data Systems, Inc. (now a part of BioClinica) and served for a time as President. Prior to that he held various positions at SmithKline Beecham, the New England Medical Center Hospital and Synectechs. Mr. Cory received his Bachelor's degree in Applied Mathematics his Master's degree in Statistics at the University of Rhode Island.
Mr. Dorsey directs global marketing, marketing operations and corporate communications for BioClinica's medical imaging, cardiovascular services, and eClinical business lines. Jim leads the daily operations of a marketing team that includes web and marketing automation technologists, graphics and content specialists, plus event and marketing managers. A resourceful senior executive with experience in product development, product management, and marketing in the pharmaceuticals, technology, and software industries, he joined BioClinica in 2009 by way of Phoenix Data Systems (PDS) and Bio-Imaging Technologies and played a pivotal role in the rebranding of these companies to BioClinica. Since then he has headed the successful marketing integration of four additional acquisitions and two major mergers. Mr. Dorsey received his Bachelor of Arts degree from Wesleyan University, in Middletown, CT, USA.
Mr. Hopper leads the Enterprise Information Technology function at BioClinica, managing Enterprise Engineering & Operations, Enterprise Applications & Business Productivity, IT Architecture and Information Security. Mr. Hopper joined BioClinica in May of 2011 and assumed the position of Vice President, Enterprise IT in October 2011. Prior to joining BioClinica, Mr. Hopper held various positions with the Wm. Wrigley Jr. Company in Chicago including leadership of the Global IT Audit function. He began his career in the Information Security Services group at Deloitte & Touche in London. He earned his Bachelor of Science at Imperial College of Science, Technology and Medicine in London, UK.
Mrs. Kraus is responsible for overseeing the global accounting, finance, tax and legal functions of BioClinica. Mrs. Kraus joined BioClinica (formerly Bio-Imaging Technologies, Inc.) January 1997 as Controller. Prior to joining the Company, Mrs. Kraus worked for Coopers & Lybrand (the predecessor of PricewaterhouseCoopers). Mrs. Kraus is a member of the Board of Directors and Executive Committee of the Girl Scouts of Eastern Pennsylvania and also serves on their Audit Committee and is Chair of the Finance Committee. Mrs. Kraus received her bachelor's degree in Accounting from Pennsylvania State University and is a certified public accountant.
Ms. LoConte manages international technology development projects and related initiatives to ensure full operational readiness for both internal and external customers. She also serves as the technology team lead for integrating acquisitions. Previously, Ms. LoConte led the daily operations of internal systems and the hosted drug safety system environment for Sentrx as Vice President of the Technology Solutions Group. Ms. LoConte also provided leadership and process knowledge in both Director and Vice President positions at Dendrite International. She began her career with Warner-Lambert Company, now Pfizer Incorporated.
Ms. Miller is responsible for BioClinica's human resources functions worldwide. Ms. Miller joined BioClinica in April 2003 as Director, Human Resources. Ms. Miller has over 10 years of leadership and human resources experience in healthcare, manufacturing, distribution and service environments including management positions at Shearon Environmental Design Company and Sysco Corporation. Ms. Miller earned her Bachelor of Arts in Mathematics from Arcadia University and her MAPP degree from the University of Pennsylvania. Ms. Miller is a certified Senior Professional in Human Resources through the HR Certification Institute at the Society for Human Resources Management.
Emmanuel Olart is responsible for imaging technology development for BioClinica's Medical Imaging Solutions Division. Mr. Olart has more than ten years of experience in software engineering and in the development and design of medical image information management systems. Mr. Olart was originally a co-founder of Theralys which was acquired by BioClinica in 2007 and held a position of Software Engineer and Information Technology Manager. He earned his Computer Science Engineering Degree from INSA in Lyon, France.
Mr. Blank is responsible for managing the day-to-day operations of BioClinica's European Headquarters in Leiden, the Netherlands. Mr. Blank joined BioClinica (formerly Bio-Imaging Technologies, Inc.) in April 2003 as Managing Director of European Office. Prior to joining the Company, Mr. Blank was Director, Clinical Trial Management at Covance Central Diagnostics and also held various other positions at Covance Central Diagnostics from 1997 to 2003. Mr. Blank also has had experience in clinical development and project management at global pharmaceutical companies. Mr. Blank received his Bachelor's degree from Academie voor Lichamelijke Opvoeding, Tilburg, the Netherlands.
Mr. Chana directs the global sales activity for BioClinica's Medical Imaging and Cardiac Safety Solutions Division and is responsible for strategic oversight of the proposal response process. Having joined BioClinica (formerly CoreLab Partners) in 2009 as an International Business Development Director, Robbie was later promoted to the role of Director, International Sales, where he managed the direct sales activities in Europe and Pan-Asia. Robbie has over 18 years of experience in clinical drug development with his career starting within the UK NHS serving as Biomedical Scientist at the bench level, developing techniques for myeloma screening as well as standardized methodology for diabetes monitoring for global phase III trials. Prior to joining the company, he held International leadership roles in Operations and Business Development for global CROs including CentraLabs, ICON, Quintiles and i3 Research. Robbie received his BSc from Leeds University, MSc from NESCOT and MBA from Kingston Business School, UK.
Mr. Endres is responsible for global business development for the Medical Imaging Solutions Division of BioClinica. Mr. Endres began his career at BioClinica (formerly Bio-Imaging Technologies, Inc.) in May 1992 as a Clinical Research Associate. Mr. Endres has held many positions including Senior Imaging Consultant, Manager of Clinical Imaging Services, Associate Director of Core Lab Services, Director of Alliance Management and Director of Business Development. Prior to joining the Company, he spent 3 years as a Staff Nuclear Medicine Technologist for the Medical Center Hospital of Vermont. Mr. Endres earned his Bachelor's degree in Nuclear Medicine Technology from the University of Wisconsin and is a certified NMTCB.
Dr. Thomas Fuerst leads the design and scientific oversight of musculoskeletal clinical trials for BioClinica. Dr. Fuerst received his Ph.D. in medical physics from the University of Wisconsin at Madison and has more than 13 years of research experience in bone densitometry, vertebral fracture methods and body composition assessment with a focus on multicenter clinical trials. Prior to joining BioClinica, he was a faculty member of the University of California, San Francisco, where he served as Director of the Quality Assurance Center and as Associate Director of the Osteoporosis and Arthritis Research Group (OARG). While at UCSF, he successfully coordinated the collection, quality control and centralized analysis of densitometry scans and imaging data for international, multi-center Phase II and Phase III clinical trials. Dr. Fuerst is also the co-founder of the imaging core lab Synarc, where he served as Scientific Director.
As an active member of the International Committee for Standards in Bone Measurement, Dr. Fuerst has worked to improve, standardize, and advance bone density technologies. He routinely consults with industry and government agencies on the use of DXA to evaluate bone mineral density and body composition.
Mr. Kisner oversees regulatory affairs, quality assurance, validation services, SOP administration and quality system training. He holds responsibility for ensuring BioClinica and its products and services comply with all regulatory standards as well as with industry best-practices. With more than 17 years of experience in the pharmaceutical and software industries, Todd has held numerous positions of increasing responsibility and joined BioClinica (formerly CoreLab Partners) in 2004 as the Director of Quality System Management. Prior to joining the company, he was responsible for driving development and validation strategies and solutions as the head of a consulting company serving the drug development industry. Todd has held key validation and compliance roles at SAS Institute and Thomson Reuters. He has been a contributor to the Metrics Champion Consortium for both ECG and Imaging and has extensive experience in GxP, Quality Assurance, SDLC and Validation Services.
Dr. Mendzelevski received his degree in Medicine and Board Certification in Internal Medicine from the Ben-Gurion University Medical School and Hospital in Beer-Sheva, Israel. He then trained in cardiology and received a board certification in Cardiology from the Shaare-Zedek Medical Centre and Hebrew University in Jerusalem, Israel. Dr. Mendzelevski completed further postgraduate training in Interventional Cardiology and Clinical Electrophysiology at the Royal Brompton National Heart and Lung Hospital in London. Dr. Mendzelevski has authored approximately 250 cardiology expert reports, most of which supported NDA regulatory submissions. He has represented pharma clients before the US FDA and the European regulatory authorities on several occasions and has participated in multiple pharmaceutical advisory boards and Data Safety Monitoring Boards (DSMBs). Dr. Mendzelevski was the only CRO expert to be invited by the FDA and ICH to serve on the ICH-E14 expert advisory panel.
A graduate of the University of Sheffield (UK) and University of Hull (UK), Dr. Colin Miller began his esteemed career in the medical science industry as a clinical researcher and quality control assurance consultant for Syntex Research and Procter & Gamble Pharmaceuticals respectively. He founded Bona Fide Ltd. in 1994, an Imaging Core Lab primarily providing quality control and services for DXA instruments being used in clinical trials. Bio-Imaging Technologies (now known as BioClinica, Inc.) acquired Bona Fide Ltd in May 1999 and retained Dr. Miller as their Vice President of Business Development. He currently serves as the Senior Vice President of BioClinica's Medical Affairs department.
Dr. Miller has shared his expertise as a contributing author for several published research articles in leading scientific journals. He is co-author of several books including Clinical Trials in Osteoporosis and Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. His latest book, Medical Imaging in Clinical Trials, was published by Springer in February of 2014.
Dr. O'Neal provides leadership and oversight to BioClinica's staff radiologists and external radiology consultants. He holds responsibility for managing the organizational planning and operational needs of the Medical Affairs department, overseeing service quality, physician training, and process improvement. Dr. O'Neal joined CoreLab Partners in 2004 as a diagnostic radiologist with more than 20 years of practice experience and has continued to provide key leadership through the 2013 BioClinica/CoreLab Partners merger. Before joining the company, Dr. O'Neal served as Chairman for the Department of Radiology at the Hospital Center at Orange from 1996-2004. Dr. O'Neal is certified by the American Board of Radiology and has been published in the Journal of Bone and Joint Surgery. He is a member of several professional organizations, including the RSNA and the American College of Radiology. Dr. O'Neal is a graduate of Rutgers University and the Universidad Autonoma de Guadalajara in Mexico, where he earned his M.D (1981).
Dr. Joyce Suhy leads the design and technical oversight of neuroscience clinical trials and provides training to staff involved in these studies. She has been working in the field of MRI and Spectroscopy for over 20 years and has a wealth of experience managing neuroscience clinical trials. Prior to joining BioClinica, Dr. Suhy worked at Synarc, where she was the VP of Neuroscience, and at SurroMed, Inc. where she was a Clinical Research Specialist responsible for the development, design, and evaluation of a standardized protocol for a multiple sclerosis program.
Dr. Suhy received a PhD in Biochemistry from Loyola University and completed a post-doctoral Research Fellowship in the Department of Radiology at the University of California at San Francisco where her work focused on utilizing MR spectroscopy and imaging to quantify metabolites within the human brain as a method to diagnose and predict the onset of neurodegenerative diseases such as epilepsy, multiple sclerosis, and amyotrophic lateral sclerosis.
Dr. Suhy is a recipient of many honors and grant awards including the Co-principal investigator NIH RO1 Grant, the Principal Investigator NIH National Research Service Award and the Principal Investigator National MS Society Fellowship. She has authored numerous journal articles and book chapters in the neuroscience therapeutic area and has participated on several expert panels to advance the use of imaging in clinical trials.
Mr. Andrus has a strategic role with BioClinica, building strong relationships across the pharmaceutical industry, including Sponsors, CROs, AROs, regulatory bodies, technology developers, and clinical research professionals. Having successfully established many of BioClinica's current service offerings, Mr. Andrus oversees the eClinical Solutions group, which works closely with customers to help them apply technologies that vastly improve the way they run clinical trials. Mr. Andrus has over 17 years of experience focused on data management, operations, quality, regulatory compliance, and eClinical technologies. Throughout his career, Mr. Andrus has shown a strong commitment to advancing research and education in the clinical research field both on a national and international level. He is 2014 Chair of the Society for Clinical Data Management (SCDM) − a position he held in 2008 as well – with the international organization leading the global conversation on data management in clinical trials. Mr. Andrus joined BioClinica in 2003, by way of Phoenix Data Systems as V.P., QA and Corporate Compliance. During various roles, he has been responsible for staff development, study operations oversight, system testing and validation, and development of SOPs, guidelines, validation protocols, and other documentation. Prior to BioClinica, Mr. Andrus managed data, oversaw and conducted clinical system validations and Part 11 & HIPAA assessments, and conducted computer system audits. Mr. Andrus has been a frequent presenter, lecturer and facilitator on a host of clinical research related topics.
Mr. Andrus is the former Chair of the Drug Information Association (DIA) eClinical Special Interest Area Community (SIAC), is a member of the DIA Advisory Council for North America (ACNA), as well as the American Society for Quality (ASQ). Mr. Andrus received a Bachelor's degree from Temple University and a Master's of Science in Quality Assurance and Regulatory Affairs from Temple University's Graduate School of Pharmacy. He is a certified quality auditor (CQA) and certified clinical data manager (CCDM).
Mr. Boccardo is responsible for business development and sales for the eClinical Solutions Division of BioClinica. Mr. Boccardo joined BioClinica (formerly Phoenix Data Systems, Inc.) in 2004 as Vice President, Sales and Marketing. Prior to joining the Company, Mr. Boccardo held various roles in sales and executive management at Liquent, Inc. Mr. Boccardo's experience also includes work as Vice President of Information Services for Bio-Pharm Clinical Services (OmniCare). He also served as a clinical programming manager at SmithKline Beecham. Mr. Boccardo received his Bachelor's degree in Mathematics from Ursinus College and his Master's in Computer Science from Villanova University.
Mr. Bowser oversees reporting, training, help desk, CTMS operations, and consulting services for the eClinical Division of BioClinica. Mr. Bowser joined BioClinica in 2012. Prior to joining the company, Mr. Bowser held various positions with Johnson & Johnson including Vice President for Drug Safety Operations and Pharmacovigilance, Vice President of the Corporate Office of Science and Technology, and Chief Information Officer for Centocor R&D, a Johnson & Johnson company. In addition, Mr. Bowser has served as Director of Project Management Operations & Systems at Pfizer, a strategy consultant with Booz Allen Hamilton and KPMG, and as a Captain in the United States Marine Corps. Mr. Bowser received his Bachelor's degree in Philosophy from Lycoming College and his MBA from Columbia University and The London Business School. He is a certified Project Management Professional (PMP).
Ms. Paccio oversees Operations for the eClinical Division of BioClinica. She has over 25 years of experience in the areas of operations, finance, strategic sourcing and program management. Prior to joining BioClinica, Ms. Paccio served as President of ‘The Sourcing Authority', a boutique consulting company that she co-founded, and before that she held senior management level positions in Global Service Operations, Global Strategy Development, HR Operations and Strategic Sourcing at GE and Dell. She is a graduate of two of GE's elite management programs, the GE Manufacturing Management Program (MMP) and GE's Corporate Audit Staff (CAS). Ms. Paccio received her Bachelor of Science degree in Mechanical & Industrial Engineering with a minor in Manufacturing Systems from Clarkson University. She also has Six Sigma training/certification from both GE and Dell.